Neuralgia Clinical Trial
Official title:
An Enriched Enrollment, Double-Blind, Placebo-Controlled, Parallel Group, Randomized Withdrawal Trial to Evaluate the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Moderate to Severe Neuropathic Pain
The present study will aim to determine the safety, efficacy, and tolerability of
etoricoxib, an NSAID pain reliever, in patients with Neuropathic pain. Neuropathic pain, or
pain caused by abnormal activity of sensory neurons, remains undertreated. Post herpetic
neuralgia (PHN), which is commonly referred to as post-shingles pain, is the most useful
disease to study when investigating the efficacy of pain relievers for Neuropathic pain.
Therefore, this study will primarily involve patients with PHN.
The hypothesis in this study is that etoricoxib efficacy is superior to that of placebo.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04066933 -
Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
|
||
| Completed |
NCT01202227 -
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
|
Phase 3 | |
| Terminated |
NCT00964990 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
|
Phase 2 | |
| Completed |
NCT00922987 -
Clinical Study With Lyrica In Patients Suffering From Epilepsy
|
||
| Recruiting |
NCT00740571 -
Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer
|
Phase 3 | |
| Terminated |
NCT02747758 -
Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy
|
N/A | |
| Completed |
NCT05464199 -
Home-based EEG Neurofeedback for Chronic Neuropathic Pain
|
Phase 1 | |
| Completed |
NCT02490436 -
Novel Treatment Option for Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT01974791 -
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT01279018 -
Persistent Pain After Breast Cancer Treatment With Docetaxel
|
N/A | |
| Not yet recruiting |
NCT00944502 -
To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins
|
Phase 3 | |
| Completed |
NCT02957851 -
EMONO for the Treatment of Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT02180880 -
Symptom Based Treatment of Neuropathic Pain
|
Phase 4 | |
| Active, not recruiting |
NCT01508676 -
Effects of Pennsaid on Clinical Neuropathic Pain
|
N/A | |
| Completed |
NCT00631943 -
A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain
|
Phase 3 | |
| Completed |
NCT03973983 -
Comparison of Ultrasound-guided Transgluteal and Finger-guided Transvaginal Pudendal Nerve Block Techniques
|
N/A | |
| Terminated |
NCT03296111 -
Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life
|
||
| Not yet recruiting |
NCT06398847 -
Virtual Reality (VR) Self-Hypnosis Software
|
N/A | |
| Terminated |
NCT02460107 -
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
|
Early Phase 1 | |
| Recruiting |
NCT01788410 -
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
|